Scientists say you can now use Osimertinib -a cancer drug- just once a week instead of daily and still be safe from tumour regrowths.
Combining hydrogen-based processes with advanced catalysts and renewable energy paves the way for developing economically and industrially viable solutions to decarbonise the steel industry